Sintx Technologies, Inc. (SINT) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Sintx Technologies, Inc. is an advanced ceramics company focused on biomedical, technical (including armor), and antipathogenic applications. The company operates manufacturing facilities in Salt Lake City, Utah, and Millersville, Maryland. As of August 8, 2024, there were 747,293 shares of common stock outstanding following a 1-for-200 reverse stock split effective May 28, 2024.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | Balance Sheet (June 30, 2024) |
|---|---|---|---|
| Total Revenue | $859,000 | $1,546,000 | - |
| Gross Profit | $635,000 | $1,099,000 | - |
| Net Loss | $(2,204,000) | $(3,090,000) | - |
| Cash and Equivalents | - | - | $4,557,000 |
| Total Debt | - | - | $241,000 |
| Derivative Liabilities | - | - | $397,000 |
| Accumulated Deficit | - | - | $(273,804,000) |
Note: All financial figures are in thousands unless otherwise noted.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 69% year-over-year for Q2 2024 ($859k vs. $508k) and 48% for the six-month period ($1.55M vs. $1.05M). This was driven by a 61% increase in product revenue and a 76% increase in grant and contract revenue.
- Expense Reduction: Total operating expenses decreased 14% in Q2 2024 compared to the prior year, primarily due to reductions in Research and Development (R&D) expenses (-22%) and General and Administrative (G&A) expenses (-8%).
- Net Loss Improvement: The net loss for Q2 2024 narrowed to $2.2M from $2.5M in Q2 2023. However, the YTD net loss widened slightly to $3.1M from $2.7M in the prior year period.
- Derivative Liability Impact: The company recognized a gain of $448,000 in Q2 2024 from the change in fair value of derivative liabilities, compared to $965,000 in Q2 2023. This non-cash gain significantly reduced the reported net loss.
Outlook, Risks, and Unusual Items
- Going Concern Warning: The company explicitly states that uncertainties regarding its ability to raise additional capital raise substantial doubt about its ability to continue as a going concern. Management notes that existing capital resources are insufficient to fund all product development and commercialization plans.
- Subsequent Events - Strategic Shifts:
- Workforce Reduction: On August 8, 2024, the Board approved a reduction in force from 40 to 23 employees, including the termination of the Executive Vice President and COO.
- Armor Plant Shutdown: On August 12, 2024, the Board decided to cease efforts to make the armor plant operational due to a malfunctioning sintering furnace. The company expects to incur an impairment charge of approximately $4.5 million in Q3 2024 related to this decision.
- Liquidity Strategy: The company is actively seeking capital through equity offerings. It has an Equity Distribution Agreement (ATM) with Maxim Group, though the amount available for sale is currently limited by public float restrictions.
- Leadership Change: Eric Olson was appointed CEO and President on August 1, 2024.
Investor Verification Checklist
- Impairment Charge Impact: Verify the timing and exact magnitude of the anticipated $4.5 million impairment charge related to the armor plant shutdown in the upcoming Q3 2024 filing.
- Cash Runway: Assess the sufficiency of the $4.6 million cash balance against the burn rate (approx. $5M operating cash outflow YTD) and the need for immediate financing.
- Derivative Liability Volatility: Monitor the fair value of derivative liabilities ($397k), as fluctuations significantly impact reported net income/loss without affecting cash flow.
- Revenue Sustainability: Confirm the durability of the 50%+ increase in grant and contract revenue, which now comprises over 55% of total revenue.
- Cost Reduction Execution: Track the actual cost savings realized from the workforce reduction (42% headcount cut) in future quarters.